# Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia

> **NCT04355637** · PHASE4 · COMPLETED · sponsor: **Sara Varea** · enrollment: 120 (actual)

## Conditions studied

- Coronavirus Infection

## Interventions

- **DRUG:** Inhaled budesonide

## Key facts

- **NCT ID:** NCT04355637
- **Lead sponsor:** Sara Varea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-21
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04355637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04355637, "Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04355637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*